摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

α-(5-(m-Xylyl))-isobuttersaeure | 93748-16-4

中文名称
——
中文别名
——
英文名称
α-(5-(m-Xylyl))-isobuttersaeure
英文别名
2-(3,5-dimethyl-phenyl)-2-methyl-propionic acid;2-(3,5-Dimethyl-phenyl)-2-methyl-propionsaeure;2-(3,5-Dimethylphenyl)-2-methylpropanoic acid
α-(5-(m-Xylyl))-isobuttersaeure化学式
CAS
93748-16-4
化学式
C12H16O2
mdl
——
分子量
192.258
InChiKey
LVVQVXGAJIMIHR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] ADAMANTYL ACETAMIDES AS HYDROXYSTEROID DEHYDROGENASE INHIBITORS<br/>[FR] ADAMANTYL ACETAMIDES UTILISES COMME INHIBITEURS DE LA HYDROXYSTEROIDE DESHYDROGENASE
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2004056744A1
    公开(公告)日:2004-07-08
    formulae (I)the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n represents an integer being 1 or 2; R1 and R2 each independently represents hydrogen C1-4alkyl, NR9R10, C1-4alkyloxy; or R1 and R2 taken together with the carbon atom with which they are attached form a C3-6cycloalkyl; and where n is 2, either R1 or R2 may be absent to form an unsaturated bond; R3 represents a C6-12cycloalkyl, preferably selected from cylo-octanyl and cyclohexyl or R3 represents a monovalent radical having one of the following formulae(a) (b) (c) (l) (q) (r) (g) (u) (o) (w) (j) (k) (t) wherein said C6-12cycloalkyl or monovalent radical may optionally be substituted with one, or where possible two, three or more substituents selected from the group consisting of C1-4alkyl, C1-4alkyloxy, halo or hydroxy; Q represents Het1 or Ar2 wherein said C3-8cycloalkyl, Het1 or Ar2 are optionally substituted with one or where possible two or more substituents selected from halo, C1-4alkyl, C1-4alkyloxy, hydroxy, nitro, NR5R6, C1-4alkyloxy substituted with one or where possible two, three or more substituents each independently selected from hydroxycarbonyl, Het2 and NR7R8, and C1-4alkyl substituted with one or where possible two or three halo substituents, preferably trifluoromethyl; R5 and R6 each independently represent hydrogen, C1-4alkyl, or C1-4alkyl substituted with phenyl; R7 and R8 each independently represent hydrogen or C1-4alkyl; R9 and R10? each independently represent hydrogen, C1-4alkyl or C1-4alkyloxycarbonyl; L represents C1-4alkyl; Het1 represents a heterocycle selected from pyridinyl, thiophenyl, or 1,3-benzodioxolyl; Het2 represents piperidinyl, pyrrolidinyl or morpholinyl; Ar2 represents phenyl, naphtyl or indenyl.
    公式(I)N-氧化物形式,其药学上可接受的加盐和立体化学异构体形式,其中n表示整数1或2;R1和R2分别表示氢C1-4烷基,NR9R10,C1-4烷氧基;或者R1和R2与它们连接的碳原子一起形成C3-6环烷基;当n为2时,R1或R2中的任一者可以缺失以形成不饱和键;R3表示C6-12环烷基,优选选择自环辛基和环己基,或者R3表示具有以下公式之一的一价基团(a)(b)(c)(l)(q)(r)(g)(u)(o)(w)(j)(k)(t),其中所述C6-12环烷基或一价基团可以选择性地用来自C1-4烷基,C1-4烷氧基,卤素或羟基的一个,或可能是两个,三个或更多个取代基取代;Q表示Het1或Ar2,其中所述C3-8环烷基,Het1或Ar2可以选择性地用来自卤素,C1-4烷基,C1-4烷氧基,羟基,硝基,NR5R6,C1-4烷氧基的一个,或可能是两个,三个或更多个取代基,每个独立选自羟基羰基,Het2和NR7R8,以及C1-4烷基的一个,或可能是两个或三个卤素取代基,优选三氟甲基;R5和R6各自独立地表示氢,C1-4烷基,或用苯基取代的C1-4烷基;R7和R8各自独立地表示氢或C1-4烷基;R9和R10各自独立地表示氢,C1-4烷基或C1-4烷氧羰基;L表示C1-4烷基;Het1表示从吡啶基,噻吩基或1,3-苯并二氧杂环烷中选择的杂环;Het2表示哌啶基,吡咯烷基或吗啉基;Ar2表示苯基,萘基或茚基。
  • CONTINUOUS METHOD FOR THE CARBONYLATION OF ALCOHOLS, IN PARTICULAR OF PHENYL ALCOHOLS
    申请人:Pilia Raimondo
    公开号:US20130281729A1
    公开(公告)日:2013-10-24
    Organic synthesis, i.e., the synthesis of carboxylic acids by direct carbonylation of alcohols in a continuous process, and more particularly, the synthesis of phenylalkylic acids, which are synthesis intermediates useful in pharmaceutical chemistry, by direct carbonylation of phenyl alkyl alcohols.
    有机合成,即通过醇的直接羰基化合成羧酸的连续过程,更具体地说,通过苯基烷基醇的直接羰基化合成对制药化学有用的合成中间体苯基烷基酸。
  • Piperdine Compound and Process for Preparing the Same
    申请人:Miyake Tsutomu
    公开号:US20070244158A1
    公开(公告)日:2007-10-18
    The present invention is to provide a piperidine compound represented by the formula [I]: wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted benzene ring, R 1 is hydrogen atom or a substituent for amino group, R 2 is hydrogen atom, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted alkyl group, a substituted carbonyl group or a halogen atom, Z is oxygen atom or —N(R 3 )—, R 3 is hydrogen atom or an optionally substituted alkyl group, R 4a and R 4b may be the same or different, and each is hydrogen atom or an optionally substituted alkyl group, or may be bonded to each other at the both ends to form an alkylene group, or a pharmaceutically acceptable salt thereof, which has an excellent tachykinin receptor antagonistic action.
    本发明提供了一种由公式[I]表示的哌啶化合物:其中,环A是可选取代的苯环,环B是可选取代的苯环,R1是氢原子或氨基取代基,R2是氢原子、可选取代的羟基、可选取代的氨基、可选取代的烷基、取代的羰基或卤原子,Z是氧原子或-N(R3)-,R3是氢原子或可选取代的烷基,R4a和R4b可以相同也可以不同,且每个都是氢原子或可选取代的烷基,或者可以在两端结合形成烷基,或其药学上可接受的盐,具有优异的Tachykinin受体拮抗作用。
  • Migrative Carbofluorination of Saturated Amides Enabled by Pd-Based Dyotropic Rearrangement
    作者:Guoqiang Yang、Hua Wu、Simone Gallarati、Clémence Corminboeuf、Qian Wang、Jieping Zhu
    DOI:10.1021/jacs.2c06578
    日期:2022.8.10
    despite the recent advances in the fields of both C–H and C–C bond activation. Herein, we report a palladium-catalyzed migrative carbofluorination of saturated amides enabled by the activation of both the C(sp3)–H and the Cquaternary–Cσ bonds. In this transformation, the α-quaternary carbon of Weinreb amides is converted to α-tertiary fluoride with concurrent migration of an aryl or an amido group from
    尽管最近在 C-H 和 C-C 键活化领域取得了进展,但直接编辑非应变无环分子的全碳季碳本身仍未得到充分利用。在此,我们报告了通过激活 C(sp 3 )-H 和 C季-Cσ 键实现的钯催化的饱和酰胺的迁移碳氟化反应。在这种转变中,Weinreb 酰胺的 α-季碳转化为 α-叔氟化物,同时芳基或酰胺基从 α-碳迁移到 β-碳。DFT 计算表明,电致重排通过一个不寻常的反-选择性[2.1.0]双环过渡态。该反应与多种官能团相容,具有立体专一性,适用于对映体富集产物的合成。
  • Compositions and methods for preparing β,γ-unsaturated acids
    申请人:California Institute of Technology
    公开号:US10336678B2
    公开(公告)日:2019-07-02
    The present disclosure provides methods for enantioselective synthesis of acyclic α-quaternary carboxylic acid derivatives via iridium-catalyzed allylic alkylation.
    本公开提供了通过铱催化烯丙基烷基化技术对映选择性合成无环 α-季羧酸衍生物的方法。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐